Amgen (AMGN) Reaffirms its 2017 Guidance

Amgen (NASDAQ: AMGN) today provided an update on Hurricane Maria's impact on the Company's manufacturing facilities in Puerto Rico. The safety of the more than 2,000 Amgen colleagues and their families on the island remains a top priority for Amgen, and outreach to impacted staff is ongoing.

"The Company's preliminary assessment is that the critical manufacturing areas in our facility in Juncos, Puerto Rico, have not been significantly impacted by this storm," said Esteban Santos, executive vice president of Operations at Amgen. "We expect to maintain our long-term track record of reliably supplying our patients with the medicines they need."

Having completed an initial review of the storm's impact, the Company reaffirms its 2017 guidance. No product nor in-process inventory has been lost, and consistent with the Company's long-standing practices, the inventory maintained by the Company and its global distribution network is sufficient to meet patient demand. Amgen has back-up generators powering the site and is working diligently with hundreds of its staff onsite to return its operations in Puerto Rico to normal as quickly as possible. In addition, the Company has manufacturing capacity at other sites around the world.

Meanwhile, the Amgen Foundation has pledged $3 million to support urgent Hurricane Maria relief efforts in Puerto Rico. The Foundation also has committed up to an additional $2 million for longer-term rebuilding efforts. Amgen has also activated its Staff Disaster Relief Fund to aid Amgen staff in Puerto Rico, including financial assistance for shelter, medical attention, clothing and other critical relief. The Amgen Foundation will also match donations made by Amgen staff around the globe who wish to contribute their own funds to the relief efforts resulting from Hurricanes Maria, Irma and Harvey, as well as the earthquakes in Mexico.

You May Also Be Interested In

• Amgen (AMGN) PT Raised to $343 at Guggenheim
• Amgen (AMGN) PT Raised to $312 at BofA Securities
• DHT Holdings Q2 TCE earnings estimated at $126,700 per day